NCT00831844 2015-03-30Cixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed116 enrolled 8 charts
NCT00331643 2014-11-14Ixabepilone in Treating Young Patients With Refractory Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed120 enrolled